Cargando…
Evaluation of UroVysion for Urachal Carcinoma Detection
Background: Patients with hematuria who are positive for urinary fluorescence in situ hybridization (FISH) are generally considered to have urothelial carcinoma. We determined whether UroVysion FISH could be used for the diagnosis of urachal carcinoma. Methods: Seven cases of urachal carcinoma with...
Autores principales: | Hu, Zhiquan, Ke, Chunjin, Liu, Zheng, Zeng, Xing, Li, Song, Xu, Hua, Yang, Chunguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482390/ https://www.ncbi.nlm.nih.gov/pubmed/32974362 http://dx.doi.org/10.3389/fmed.2020.00437 |
Ejemplares similares
-
UroVysion(TM) Fluorescence In Situ Hybridization in Urological Cancers: A Narrative Review and Future Perspectives
por: Ke, Chunjin, et al.
Publicado: (2022) -
UroVysion(™) fluorescence in situ hybridization (FISH) possibly has a high positive rate in carcinoma of non-urothelial lineages
por: Ke, Chunjin, et al.
Publicado: (2023) -
UroVysion fluorescence in situ hybridization (UroVysion FISH) assay for detection of bladder cancer in voided urine of Turkish patients: a preliminary study
por: Dodurga, Yavuz, et al.
Publicado: (2013) -
Refined pancreatobiliary UroVysion criteria and an approach for further optimization
por: Mettman, Daniel, et al.
Publicado: (2021) -
A prospective comparison of UroVysion FISH and urine cytology in bladder cancer detection
por: Lavery, Hugh J., et al.
Publicado: (2017)